Cookie Policy

Athenex, Inc.

Filing Date
May 14, 2023
Case Number
23-90295
District
Southern District of Texas

Assets: $100M-$500M

Liabilities: $100M-$500M

Docket

On May 14, 2023 Athenex, Inc. filed for chapter 11 protection in the Southern District of Texas (Case No. 23-90295). The Debtor reports Assets of $100M-$500M and Liabilities of $100M-$500M. The Petition states funds will be available to Unsecured Creditors.

Per Claims Agent:
Debtor Represented by:

Michael D Warner

Pachulski Stang Ziehl & Jones LLP


Company Information:
Address:

Conventus Building

1001 Main Street

Suite 600

Map to Debtor
Website:
https://www.athenex.com
Description:
Athenex.com is a pharmaceutical company that specializes in oncology, immuno-oncology, and targeted therapies. Their products and services include research and development of innovative cancer treatments, as well as manufacturing and commercialization ...
Industry:
Pharmaceuticals

Share this Filing

Press Release:
Note: we do not represent the Debtor in this case and this information is obtained from automated sources and may not be 100% accurate.
Petition image
Petition
Computer image
New! Dockets